Widespread infections early in the year weigh on Merck Q1 :

Widespread infections early in the year weigh on Merck Q1


New era begins at Merck as pandemic cuts Q1 sales, profit
LINDA A. JOHNSON, AP Medical Writer
April 29, 2021
FacebookTwitterEmail
FILE - In this Dec. 18, 2014, file photo, a person walks through a Merck company building in Kenilworth, N.J. COVID-19 infections weighed Merck with so many people avoiding visits to hospitals or even the doctor early in the first quarter. The pharmaceutical company on Thursday, April 29, 2021, reported first-quarter earnings of $3.18 billion.Mel Evans/AP
Merck is entering a new era, with sweeping changes across its executive suite and the spinoff off its women's health and other businesses, a bid to enable both resulting companies to grow faster.

Related Keywords

, Zacks Investment Research , Merck Co , Zacks Investment , Automated Insights , Kenneth Frazier Business Leader Person , Ben Frazier , Caroline Litchfield , Rob Davis , Sean Li , Frank Clyburn , Michael Nally , O , Black , Roger Perlmutter , Lindaa Johnson , Biden , Keytruda , Covid 19 , Kenilworth , New Jersey , Merck , P , C Complete State National , Gilead Sciences , Organon , Usiness Stories , Op News , Anumet , Januvia , Nasonex , Singulair , Usiness News , F Wire , Hoice Plus , Covid , Merck Results , Pandion Therapeutics , Wall Street , Ttps Twitter Com Lindaj Onpharma , ஜாக்கக்ஸ் முதலீடு ஆராய்ச்சி , மெர்க் இணை , ஜாக்கக்ஸ் முதலீடு , தானியங்கி நுண்ணறிவு , ஓ , பற்றாக்குறை , விட் , ப் , ஓப் செய்தி , எஃப் கம்பி , அனைத்தும் தெரு ,

© 2025 Vimarsana